NGFR and cancer: However, there are currently no studies demonstrating p75NTR’s effects on modulating the immune response in cancer, nor in acute or chronic brain disease suggesting this area may warrant further investigation, noting also the fact that p75NTR belongs to tumor necrosis factor receptor superfamily.